Article
Glucagon receptor inactivation leads to α-cell hyperplasia in zebrafish
1 Nov 2015
Abstract excerpt
Glucagon antagonism is a potential treatment for diabetes. One potential side effect is α-cell hyperplasia, which has been noted in several approaches to antagonize glucagon action. To investigate the molecular mechanism of the α-cell hyperplasia and to identify the responsible factor, we created a zebrafish model in which glucagon receptor (gcgr) signaling has been interrupted. The genetically and chemically...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
